+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
Alvimopan (CAS 156053-89-3) Global Market Research Report 2024 - Product Thumbnail Image

Alvimopan (CAS 156053-89-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Balsalazide (CAS 80573-04-2) Global Market Research Report 2024 - Product Thumbnail Image

Balsalazide (CAS 80573-04-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Bemesetron (CAS 40796-97-2) Global Market Research Report 2024 - Product Thumbnail Image

Bemesetron (CAS 40796-97-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Benexate (CAS 78718-52-2) Global Market Research Report 2024 - Product Thumbnail Image

Benexate (CAS 78718-52-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Ezlopitant (CAS 147116-64-1) Global Market Research Report 2024 - Product Thumbnail Image

Ezlopitant (CAS 147116-64-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Almagate (CAS 66827-12-1) Global Market Research Report 2024 - Product Thumbnail Image

Almagate (CAS 66827-12-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Androisoxazole (CAS 360-66-7) Global Market Research Report 2024 - Product Thumbnail Image

Androisoxazole (CAS 360-66-7) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Batanopride (CAS 102670-46-2) Global Market Research Report 2024 - Product Thumbnail Image

Batanopride (CAS 102670-46-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Alizapride (CAS 59338-93-1) Global Market Research Report 2024 - Product Thumbnail Image

Alizapride (CAS 59338-93-1) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Dicyclomine (CAS 77-19-0) Global Market Research Report 2024 - Product Thumbnail Image

Dicyclomine (CAS 77-19-0) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Ethylestrenol (CAS 965-90-2) Global Market Research Report 2024 - Product Thumbnail Image

Ethylestrenol (CAS 965-90-2) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Diisopromine (CAS 5966-41-6) Global Market Research Report 2024 - Product Thumbnail Image

Diisopromine (CAS 5966-41-6) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Cetraxate (CAS 34675-84-8) Global Market Research Report 2024 - Product Thumbnail Image

Cetraxate (CAS 34675-84-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
Clebopride (CAS 55905-53-8) Global Market Research Report 2024 - Product Thumbnail Image

Clebopride (CAS 55905-53-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Clostebol (CAS 1093-58-9) Global Market Research Report 2024 - Product Thumbnail Image

Clostebol (CAS 1093-58-9) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more